Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Gross Margin (2022)

Historic Gross Margin for Abeona Therapeutics (ABEO) over the last 8 years, with Q2 2025 value amounting to 75.0%.

  • Abeona Therapeutics' Gross Margin changed N/A to 75.0% in Q2 2025 from the same period last year, while for Sep 2025 it was 54.5%, marking a year-over-year change of. This contributed to the annual value of 54.14% for FY2023, which is 140300.0% down from last year.
  • Abeona Therapeutics' Gross Margin amounted to 75.0% in Q2 2025.
  • Abeona Therapeutics' Gross Margin's 5-year high stood at 75.0% during Q2 2025, with a 5-year trough of 47.06% in Q4 2022.
  • Over the past 3 years, Abeona Therapeutics' median Gross Margin value was 60.0% (recorded in 2022), while the average stood at 36.99%.
  • Examining YoY changes over the last 5 years, Abeona Therapeutics' Gross Margin showed a top increase of -100000bps in 2023 and a maximum decrease of -100000bps in 2023.
  • Abeona Therapeutics' Gross Margin (Quarter) stood at 47.06% in 2022, then skyrocketed by 217bps to 55.0% in 2023, then skyrocketed by 36bps to 75.0% in 2025.
  • Its Gross Margin stands at 75.0% for Q2 2025, versus 55.0% for Q2 2023 and 47.06% for Q4 2022.